Semi-allogeneic vaccine for T-cell lymphoma

Semi-allogeneic vaccine for T-cell lymphoma

<p>Abstract</p> <p>Background</p> <p>Experimental results from studies with inbred mice and their syngeneic tumors indicated that the inoculation of semi-allogeneic cell hybrids (derived from the fusion between syngeneic tumor cells and an allogeneic cell line) protects...

Full description

Bibliographic Details
Main Authors:	Kindy Mark S, Yu Jin, Gattoni-Celli Sebastiano
Format:	Article
Language:	English
Published:	BMC 2007-08-01
Series:	Journal of Translational Medicine
Online Access:	http://www.translational-medicine.com/content/5/1/39

Similar Items

Semi-allogeneic vaccines and tumor-induced immune tolerance
by: Kindy Mark S, et al.
Published: (2009-01-01)

Restoration of Immune Responsiveness to Glioma by Vaccination of Mice with Established Brain Gliomas with a Semi-Allogeneic Vaccine
by: Sebastiano Gattoni-Celli, et al.
Published: (2016-09-01)

Allogeneic Hematopoietic Stem Cell Transplantation in Cutaneous T-Cell Lymphomas
by: Maëlle Dumont, et al.
Published: (2020-10-01)

Peripheral T-cell Lymphomas: Updates in Allogeneic Hematopoietic Stem Cell Transplantation
by: Wen-Rong Huang, et al.
Published: (2018-01-01)

Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma
by: Atae Utsunomiya
Published: (2019-10-01)

Impact of Autologous and Allogeneic Stem Cell Transplantation in Peripheral T-Cell Lymphomas
by: Peter Reimer
Published: (2010-01-01)

Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma—Romanian Experience
by: Alina D. Tanase, et al.
Published: (2020-07-01)

Allogenic tumour vaccines for melanoma
by: Kayaga, Justina
Published: (2000)

Tackling mantle cell lymphoma (MCL): Potential benefit of allogeneic stem cell transplantation
by: Satish Shanbhag, et al.
Published: (2010-07-01)

The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma Patients
by: Evgeny Klyuchnikov, et al.
Published: (2011-01-01)

Allogeneic stem cell transplantation for relapsed primary central nervous system lymphoma: Is it feasible?
by: Erden Atilla, et al.
Published: (2019-12-01)

Outcomes of allogeneic hematopoietic stem cell transplantation for lymphomas: a single-institution experience
by: Mira Romany Massoud, et al.

Reduced-intensity conditioning allogeneic stem cell transplantation in malignant lymphoma: current status
by: Le Zhang, et al.
Published: (2013-03-01)

CURRENT ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA
by: Luca Castagna, et al.
Published: (2015-02-01)

THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
by: Francesco Maura, et al.
Published: (2016-09-01)

Results of allogeneic hematopoietic stem cell transplantation in a patient with classical Hodgkin's lymphoma
by: A. Р. Strelnikova, et al.
Published: (2021-05-01)

Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma in the Era of New Drugs and CAR-T Cell Therapy
by: Miriam Marangon, et al.
Published: (2021-01-01)

Allogenic γδ T cell and tumor cell fused vaccine for enhanced immunotherapeutic efficacy of osteosarcoma
by: Yitian Wang, et al.
Published: (2020-04-01)

Romidepsin Used as Monotherapy in Sequence with Allogeneic Stem Cell Transplant in a Patient with Peripheral T-Cell Lymphoma
by: Nicholas Finn, et al.
Published: (2014-01-01)

Periodic accumulation of regulatory T cells in the uterus: preparation for the implantation of a semi-allogeneic fetus?
by: Marinos Kallikourdis, et al.
Published: (2007-04-01)

Tumor vaccine strategies after allogeneic T-cell depleted bone marrow transplantation
by: Ferrara James L.M.
Published: (2002-01-01)

Allogeneic Antigen Composition for Preparing Universal Cancer Vaccines
by: Petr G. Lokhov, et al.
Published: (2016-01-01)

Treatment of splenic marginal zone lymphoma of the CNS with high-dose therapy and allogeneic stem cell transplantation
by: Busemann Christoph, et al.
Published: (2012-10-01)

The Impact of Achieving Complete Remission Prior to Allogeneic Stem Cell Transplantation on Progression-Free Survival in Hodgkin Lymphoma
by: Nadira Duraković, et al.
Published: (2021-07-01)

Uveitis and Myositis as Immune Complications in Chemorefractory NK/T-Cell Nasal-Type Lymphoma Successfully Treated with Allogeneic Stem-Cell Transplant
by: Maria José Gómez-Crespo, et al.
Published: (2016-01-01)

Allogeneic Stem Cell Transplantation with a Novel Reduced Intensity Conditioning Regimen for the Treatment of Patients with Primary Cutaneous T-cell Lymphomas
by: Maria Stamouli, et al.
Published: (2021-06-01)

Outcomes in relapsed Hodgkin's lymphoma treated with autologous and allogeneic hematopoietic cell transplantation at the Pontiﬁcia Universidad Católica de Chile
by: Pablo Ramirez, et al.
Published: (2015-06-01)

Idiotypic vaccination against a B-cell lymphoma
by: Dyke, Rebecca Jane
Published: (1990)

A multicenter retrospective study on the real-world outcomes of autologous vs. allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphoma in China
by: Zhen-Yang Gu, et al.
Published: (2021-07-01)

Design and characterization of the tumor vaccine MGN1601, allogeneic fourfold gene-modified vaccine cells combined with a TLR-9 agonist
by: Barbara Volz, et al.
Published: (2016-01-01)

Progression and CSF Inflammation after Eradication of Oligoclonal Bands in an MS Patient Treated with Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma
by: P. Braendstrup, et al.
Published: (2012-06-01)

Reduced-Intensity Allogeneic Stem Cell Transplantation for Co-Emergence of Chemotherapy-Refractory Follicular Lymphoma and Therapy-Related Myelodysplastic Syndrome
by: Yuji Shimura, et al.
Published: (2014-03-01)

Alectinib, an anaplastic lymphoma kinase (ALK) inhibitor, as a bridge to allogeneic stem cell transplantation in a patient with ALK‐positive anaplastic large‐cell lymphoma refractory to chemotherapy and brentuximab vedotin
by: Ritsuko Nakai, et al.
Published: (2019-12-01)

Early relapse of Burkitt lymphoma heralded by a bone marrow necrosis and numb chin syndrome successfully treated with allogeneic stem cell transplantation
by: Jan Cerny, et al.
Published: (2014-01-01)

The construction of a lymphoma cell-based, DC-targeted vaccine, and its application in lymphoma prevention and cure
by: Tianlin Zhou, et al.
Published: (2021-03-01)

The safety and efficacy of a novel hypo-fractionated total marrow and lymphoid irradiation before allogeneic stem cell transplantation for lymphoma and acute leukemia
by: Liu Shi, et al.
Published: (2021-01-01)

A novel cancer vaccine strategy based on HLA-A*0201 matched allogeneic plasmacytoid dendritic cells.
by: Caroline Aspord, et al.
Published: (2010-01-01)

Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphoma
by: Narendranath Epperla, et al.
Published: (2017-06-01)

LYMPHOID NEOPLASMS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION. THE CASE OF SECONDARY HODGKIN’S LYMPHOMA, DIFFERENTIAL DIAGNOSIS WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
by: Yu. V. Skvortsova, et al.
Published: (2017-06-01)

Regulatory T Cells in Allogeneic Stem Cell Transplantation
by: Maria Michael, et al.
Published: (2013-01-01)